| Literature DB >> 34978569 |
Sarah Cuschieri1, Elena Pallari2, Amalia Hatziyianni3, Rannveig Sigurvinsdottir4, Inga Dora Sigfusdottir4,5,6, Árún Kristín Sigurðardóttir7,8.
Abstract
BACKGROUND: COVID-19 became a global pandemic within weeks, as every country including small states and islands experienced a surge in cases. Small islands are known to face several challenges in the quest to curb the viral spread, but with the absence of land boarders and small population size, these factors should have played to their advantage to minimize the spread. The aim of this article was to compare and contrast the COVID-19 situation, restrictions, preparedness, management and the healthcare systems between the small population island states of Cyprus, Iceland and Malta.Entities:
Mesh:
Substances:
Year: 2022 PMID: 34978569 PMCID: PMC8755372 DOI: 10.1093/eurpub/ckab217
Source DB: PubMed Journal: Eur J Public Health ISSN: 1101-1262 Impact factor: 4.424
Figure 1Comparison of the excess mortality for Cyprus, Iceland and Malta over a year
Figure 2Comparison of the COVID-19 7-day moving average of positive cases and instituted measures/relaxations in Cyprus, Iceland and Malta over a year. GR – gradual relaxation of measures across the three Islands; Cyprus – opens airports and ports on 9th of June 2020; Malta – opens airport and ports on 1st July 2020; Iceland – new scholastic year started on 14th August 2020; Cyprus – new scholastic year started on 13th September 2020; Malta – new scholastic year started on 7th October 2020; Cyprus – schools shifted to online on 27th November 2020; Yellow shading – Christmas-New Year period; Pink shading – Carnival period in Malta
Figure 3Comparison between positivity rate moving average and mortality rate per week (March 2020 to March 2021). (A) Comparisons between Cyprus, Iceland and Malta; (B) Comparison for Cyprus; (C) Comparison for Iceland; (D) Comparison for Malta.
Comparative Covid-19 vaccination statistics across Cyprus, Iceland and Malta
| Cyprus | Iceland | Malta | ||
|---|---|---|---|---|
| Vaccination |
|
|
| |
| Fully vaccinated | 6773 per 10 000 | 8453 per 100 000 | 20 844 per 100 000 | |
| One dose | 178 300 per 10 000 | 18 062 per 100 000 | 44 912 per 100 000 | |
| Vaccines available | ||||
| Pfizer-BioNTech | Yes from 27 December 2020 | Yes from 29 December 2020 | Yes from 27 December 2020 | |
| Moderna | Yes | Yes from 13 January 2021 | Yes from 11 January 2021 | |
| Oxford/AstraZenea | Yes | Yes from 11 February 2021 | Yes from 14 February 2021 | |